Didn’t they say the same thing about Finasteride, Dutasteride etcetera? It wasn’t until years later that they were forced to add additional clauses to the prescription.
As far as I can tell this Clasocoterone (Breezula) targets the AR receptors. If PFS patients are in whatever way linked by certain sensitivities regarding the AR receptors than this medicine could be just as dangerous as 5AR inhibitors for all we know. We simply don’t know if 5ar inhibition is truly the only cause of our symptoms.
I wouldn’t be so quick to assume that Breezula is safe given our experiences with promises of safety in the past regarding antiandrogenic substances.
That said, even if a better alternative comes to the market. Parties involved in the Finasteride trade will still try to dimiss the dangers of Finasteride as they always have and sell it as they always have. I highly doubt they are suddenly going to admit it was poison all along when something else hits the market. With the recent commercialization of Finasteride I still think we’re still going to see an enormous influx of PFS patients the coming years.